• / Free eNewsletters & Magazine
  • / My Account
Home>Paul Larson

Paul Larson

  1. All
  2. Morningstar Articles
  3. Videos
  4. Investing
  1. The Winners and Losers in a Changing Mortgage Market

    Increased regulation could advantage high-tech disrupters and firms with economies of scale, says Morningstar's Jim Sinegal.

  2. Friday Five: The Ones You Don't See Coming

    We break down this week's Swiss surprise. Plus, our take on big bank results, Tiffany's sell-off, and Priceline's new 5-star status.

  3. Approach the Mining Sector With Caution

    A likely slowdown in Chinese real estate will mean weaker demand for commodities such as iron ore and copper, but a few firms with sustainable low-cost positions should weather the storm.

  4. Opportunities in Internet Stocks

    Focused on sustainable competitive advantages and sensitive to valuation, Morningstar StockInvestor's Matt Coffina sees potential in a handful of Internet stocks today.

  5. Larson's Strategies for Excess Returns

    StockInvestor editor Paul Larson discusses the importance of investing in companies that can compound their intrinsic values, buying on the cheap, avoiding stop-loss orders, and more.

  6. How to Protect From Black Swans and Black Boxes

    The financial crisis proved that tumultuous events can and do happen, and investors need to keep a long-term perspective in a market that is incredibly short-term focused, says StockInvestor editor Paul Larson .

  7. A Rare Time for Wide-Moat Stocks?

    StockInvestor editor Paul Larson details recent changes to Morningstar's Wide Moat Focus Index, noting how the rally in wide-moat names could have them more fairly priced than lower-quality stocks.

  8. Reasons to Be Cautious on Midstream MLPs

    After his recent sale of Energy Transfer Equity, StockInvestor editor Matt Coffina says investors should consider more conservative MLPs whose current valuations are less dependent on future growth.

  9. Our 2014 Big Pharma Pipeline Rankings: Who Came Out on Top?

    Merck's reinvigorated pipeline and Sanofi's minimal patent-loss exposure placed them atop our rankings this year, while GlaxoSmithKline joined Pfizer toward the bottom.

  10. MLPs: High-Quality Income Generators

    Tax advantages and economic moats allow master limited partnerships to offer investors much more than just high yields, says Morningstar's Paul Larson .

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.